We recently showed that cytoplasmic γ-actin (γ cyto -actin) is dramatically elevated in striated muscle of dystrophin-deficient mdx mice. Here we demonstrate that γ cyto -actin is markedly increased in golden retriever muscular dystrophy (GRMD), which better recapitulates the dystrophinopathy phenotype in humans. γ cyto -Actin was also elevated in muscle from α-sarcoglycan null mice, but not in several other dystrophic animal models, including mice deficient in β-sarcoglycan, α-dystrobrevin, laminin-2, or α7 integrin. Muscle from mice lacking dystrophin and utrophin also expressed elevated γ cyto -actin, which was not restored to normal by transgenic overexpression of α7 integrin. However, γ cyto -actin was further elevated in skeletal muscle from GRMD animals treated with the glucocorticoid prednisone at doses shown to improve the dystrophic phenotype and muscle function. These data suggest that elevated γ cyto -actin is part of a compensatory cytoskeletal remodeling program that may partially stabilize dystrophic muscle in some cases where the dystrophinglycoprotein complex is compromised.